
Company valuation, historical trends, and peer comparisons.
According to Ascletis Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.77B. This represents a change of -41.72% compared to the average of 6.46B of the last 4 quarters.
The mean historical Enterprise Value of Ascletis Pharma Inc. over the last ten years is 4.15B. The current 3.77B Enterprise Value has changed -9.26% with respect to the historical average. Over the past ten years (40 quarters), ASCLF's Enterprise Value was at its highest in in the June 2017 quarter at 14.04B. The Enterprise Value was at its lowest in in the December 2020 quarter at -195984355.22.
Average
4.15B
Median
1.83B
Minimum
-192427209.33
Maximum
13.62B
Discovering the peaks and valleys of Ascletis Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 364.81%
Maximum Annual Enterprise Value = 13.62B
Minimum Annual Increase = -332.90%
Minimum Annual Enterprise Value = -192427209.33
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 8.51B | 331.25% |
| 2024 | 1.97B | 79.52% |
| 2023 | 1.10B | -47.23% |
| 2022 | 2.08B | 364.81% |
| 2021 | 448.16M | -332.90% |
| 2020 | -192427209.33 | 2.61% |
| 2019 | -187534024.49 | -111.13% |
| 2018 | 1.68B | -86.47% |
| 2017 | 12.45B | -8.60% |
The current Enterprise Value of Ascletis Pharma Inc. (ASCLF) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
3.86B
5-year avg
2.82B
10-year avg
4.15B
Ascletis Pharma Inc.’s Enterprise Value is greater than Brii Biosciences Limited (130.16M), greater than HighTide Therapeutics Inc (1.45B), greater than HUTCHMED (China) Limited (2.53B), less than Shanghai Henlius Biotech, Inc. (26.64B), less than Innovent Biologics, Inc. (116.14B), less than InnoCare Pharma Limited (11.75B), greater than Zai Lab Limited (2.52B), less than Laekna, Inc. (0), less than CStone Pharmaceuticals (6.59B), less than Lepu Biopharma Co., Ltd. (5.15B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 130.16M | $739.58M | |
| 1.45B | $1.84B | |
| 2.53B | $19.92B | |
| 26.64B | $27.67B | |
| 116.14B | $154.42B | |
| 11.75B | $18.22B | |
| 2.52B | $22.56B | |
| 0 | $2.74B | |
| 6.59B | $8.98B | |
| 5.15B | $5.48B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascletis Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ascletis Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ascletis Pharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ascletis Pharma Inc. (ASCLF)?
What is the 3-year average Enterprise Value for Ascletis Pharma Inc. (ASCLF)?
What is the 5-year average Enterprise Value for Ascletis Pharma Inc. (ASCLF)?
How does the current Enterprise Value for Ascletis Pharma Inc. (ASCLF) compare to its historical average?